Cost effectiveness of Oncotype DX test in patients with early-stage breast cancer in a middle-income country, Turkey: results of a prospective multicenter study

Sadeleştirilmiş öğe sayfası
dc.contributor.authorOzmen, V.
dc.contributor.authorGokmen, E.
dc.contributor.authorAtasoy, A.
dc.contributor.authorOzdogan, M.
dc.contributor.authorGuler, N.
dc.contributor.authorUras, C.
dc.contributor.authorOk, E.
dc.contributor.authorDemircan, O.
dc.contributor.authorIsikdogan, A.
dc.contributor.authorSaip, P.
dc.date.accessioned2025-10-16T15:27:33Z
dc.date.issued2017
dc.identifier.doi10.1016/S0960-9776(17)30275-8
dc.identifier.otherWOS:000397930400218
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/8542
dc.publisherCHURCHILL LIVINGSTONE
dc.sourceBREAST
dc.titleCost effectiveness of Oncotype DX test in patients with early-stage breast cancer in a middle-income country, Turkey: results of a prospective multicenter study
dc.typeMeeting Abstract

Dosyalar

Koleksiyonlar

WOS